Zentek

Update in progress

ZTEK (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

Zentek Ltd. conducts research and development of graphene and related nanomaterials in Canada. It develops ZenGUARD graphene-based antimicrobial coatings and products such as surgical masks, HVAC filters, and PPE, along with rapid point-of-care diagnostics and graphene-based pharmaceutical compounds. The company also works on aptamers, graphene oxide and graphene synthesis, and owns the Albany graphite project in Northern Ontario. Formerly ZEN Graphene Solutions Ltd., renamed in Oct 2021. Incorporated 2008; headquartered in Guelph, Ontario.

Company score

Sentiment: 0.49; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.31; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.33; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.15; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.24; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.36; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive